This study is not yet accepting patients
Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at San Francisco, California
- Dates
- study startedcompletion around
- Principal Investigator
- by Matthew Spinelli, MD, MAS
Description
Summary
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Matthew Spinelli, MD, MAS
I am HIV/ID physician with training in implementation science methods who uses these approaches to support pre-exposure prophylaxis (PrEP) implementation, PrEP/HIV ART adherence, and PrEP persistence/HIV retention in care. A key tool we are using in this work is a point-of-care urine tenofovir test that can provide real-time adherence information to clinicians to drive adherence interventions.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT06414408
- Phase
- Phase 1 Sexually Transmitted Infections Research Study
- Study Type
- Interventional
- Participants
- Expecting 48 study participants
- Last Updated